Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuejun Chen

Showing results (291-300 of 327) with videos related to

Pageof 33
Sort By:
Structure (London, England : 1993)|July 16, 2022
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerabilityWei Shi, Lingshu Wang, Tongqing Zhou, et al.
Science Immunology|August 8, 2017
Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humansSarah F Andrews, M Gordon Joyce, Michael J Chambers, et al.
NPJ Vaccines|April 27, 2026
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Immunity|December 16, 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan BarrierMattia Bonsignori, Eric Scott, Kevin Wiehe, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapyNicolas M S Galvez, Yi Cao, Adam D Nitido, et al.
Cell Reports|May 31, 2024
Cholesterol reduction by immunization with a PCSK9 mimicBaoshan Zhang, Gwo-Yu Chuang, Andrea Biju, et al.
Nature Medicine|May 15, 2024
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trialXiaohua Wu, Jihong Liu, Jing Wang, et al.
Nature Medicine|March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesAnn J Hessell, J Pablo Jaworski, Erin Epson, et al.
Plos Pathogens|September 19, 2019
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Pageof 33

Showing results (291-300 of 327) with videos related to

Sort By:
Pageof 33
Structure (London, England : 1993)|July 16, 2022
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerabilityWei Shi, Lingshu Wang, Tongqing Zhou, et al.
Science Immunology|August 8, 2017
Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humansSarah F Andrews, M Gordon Joyce, Michael J Chambers, et al.
NPJ Vaccines|April 27, 2026
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Immunity|December 16, 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan BarrierMattia Bonsignori, Eric Scott, Kevin Wiehe, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapyNicolas M S Galvez, Yi Cao, Adam D Nitido, et al.
Cell Reports|May 31, 2024
Cholesterol reduction by immunization with a PCSK9 mimicBaoshan Zhang, Gwo-Yu Chuang, Andrea Biju, et al.
Nature Medicine|May 15, 2024
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trialXiaohua Wu, Jihong Liu, Jing Wang, et al.
Nature Medicine|March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesAnn J Hessell, J Pablo Jaworski, Erin Epson, et al.
Plos Pathogens|September 19, 2019
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Pageof 33